Analytical Data
-
Gene name
MOSC1
- Application
-
Alternative Names
Molybdenum Cofactor Sulphurase C-Terminal Domain Containing Protein; Mitochondrial amidoxime-reducing component 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5VT66
-
Expression Region
Arg41~Leu335
-
Molecular Weight
37kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MOSC1, or Mitosuppressor Component 1, is a highly conserved protein implicated in various cellular processes, including mitochondrial function and cellular stress responses. Its study has gained traction due to its potential role in cancer biology and cellular homeostasis. Research has shown that MOSC1 is involved in the regulation of mitochondrial dynamics, promoting the repair and maintenance of mitochondrial integrity. Dysregulation of MOSC1 expression has been linked to various pathologies, including neurodegenerative diseases and cancer, where its aberrant signaling may influence tumorigenesis and metastasis. The exploration of MOSC1 as a recombinant protein holds promise for unraveling its biochemical pathways and interactions, which can provide insights into its functional roles within the cell. Furthermore, the development of MOSC1-based therapeutics could offer novel strategies for targeting mitochondrial dysfunctions in disease contexts. Understanding the molecular mechanisms mediated by MOSC1 and its interactions with various cellular components is critical for elucidating its contributions to both normal physiology and disease progression. Thus, extensive research into the recombinant production and characterization of MOSC1 is essential for advancing our knowledge of its biological significance and therapeutic potential.
